Are Things Looking Up For Galera Therapeutics Inc (NASDAQ: GRTX)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.18 and fluctuated between $0.1837 as its day high and $0.1730 as its day low. The current market capitalization of Galera Therapeutics Inc is $9.76M. A total of 0.55 million shares were traded on the day, compared to an average of 2.47M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, GRTX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 3 BUYs and 0 SELLs from insiders. Insiders purchased 121,000 shares during that period but sold 0.

In the most recent transaction, Bachleda Mark bought 11,000 shares of GRTX for 2.25 per share on Mar 16. After the transaction, the Chief Commercial Officer now owns 11,000 company shares. In a previous transaction on Mar 13, Degnan Chris bought 10,000 shares at 1.96 per share. GRTX shares that Chief Financial Officer owns now total 10,000.

Among the insiders who bought shares, Sorensen Mel acquired of 100,000 shares on Mar 10 at a per-share price of $1.68. This resulted in the President and CEO holding 332,044 shares of GRTX after the transaction.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, GRTX has a high of $3.59 and a low of $0.09.

As of this writing, GRTX has an earnings estimate of $Vertex Pharmaceuticals Incorpor per share for the current quarter. EPS was calculated based on a consensus of RTX Corporation estimates, with a high estimate of $Gritstone bio, Inc. per share and a lower estimate of $Heron Therapeutics, Inc.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GRTX’s latest balance sheet shows that the firm has $71.22M in Cash & Short Term Investments as of fiscal 2021. There were $302.00k in debt and $12.94M in liabilities at the time. Its Book Value Per Share was -$2.36, while its Total Shareholder’s Equity was -$58.00M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GRTX is Buy with a score of 3.00.

Most Popular

Related Posts